866-997-4948(US-Canada Toll Free)

United States mRNA Vaccines & Therapeutics Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 113 Pages

In this report, the United States mRNA Vaccines & Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of mRNA Vaccines & Therapeutics in these regions, from 2012 to 2022 (forecast).

United States mRNA Vaccines & Therapeutics market competition by top manufacturers-players, with mRNA Vaccines & Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer-player; the top players including
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
On the basis on the end users-applications, this report focuses on the status and outlook for major applications-end users, sales volume, market share and growth rate of mRNA Vaccines & Therapeutics for each application, including
Application 1
Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States mRNA Vaccines & Therapeutics Market Report 2017
1 mRNA Vaccines & Therapeutics Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Classification of mRNA Vaccines & Therapeutics by Product Category
1.2.1 United States mRNA Vaccines & Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States mRNA Vaccines & Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Standardization Of Cancer Treatment MRNA Vaccine
1.2.4 Individualized Cancer Treatment MRNA Vaccine
1.2.5 Infectious Disease Treatment MRNA Vaccine
1.2.6 Infection Prevention MRNA Vaccine
1.3 United States mRNA Vaccines & Therapeutics Market by Application-End Users
1.3.1 United States mRNA Vaccines & Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.1 Application 1
1.3.2 Application 2
1.4 United States mRNA Vaccines & Therapeutics Market by Region
1.4.1 United States mRNA Vaccines & Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
1.4.3 Southwest mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
1.4.5 New England mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
1.4.6 The South mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
1.4.7 The Midwest mRNA Vaccines & Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of mRNA Vaccines & Therapeutics (2012-2022)
1.5.1 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 United States mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2022)

2 United States mRNA Vaccines & Therapeutics Market Competition by Players-Suppliers
2.1 United States mRNA Vaccines & Therapeutics Sales and Market Share of Key Players-Suppliers (2012-2017)
2.2 United States mRNA Vaccines & Therapeutics Revenue and Share by Players-Suppliers (2012-2017)
2.3 United States mRNA Vaccines & Therapeutics Average Price by Players-Suppliers (2012-2017)
2.4 United States mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
2.4.1 United States mRNA Vaccines & Therapeutics Market Concentration Rate
2.4.2 United States mRNA Vaccines & Therapeutics Market Share of Top 3 and Top 5 Players-Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players-Suppliers mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States mRNA Vaccines & Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States mRNA Vaccines & Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States mRNA Vaccines & Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States mRNA Vaccines & Therapeutics Price by Region (2012-2017)

4 United States mRNA Vaccines & Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States mRNA Vaccines & Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States mRNA Vaccines & Therapeutics Price by Type (2012-2017)
4.4 United States mRNA Vaccines & Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States mRNA Vaccines & Therapeutics Sales (Volume) by Application (2012-2017)
5.1 United States mRNA Vaccines & Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States mRNA Vaccines & Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States mRNA Vaccines & Therapeutics Players-Suppliers Profiles and Sales Data
6.1 Argos Therapeutics
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business-Business Overview
6.2 AstraZeneca
6.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business-Business Overview
6.3 Bayer
6.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bayer mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business-Business Overview
6.4 BioNTech
6.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business-Business Overview
6.5 Boehringer Ingelheim
6.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business-Business Overview
6.6 CRISPR Therapeutics
6.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business-Business Overview
6.7 CureVac
6.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business-Business Overview
6.8 eTheRNA immunotherapies
6.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business-Business Overview
6.9 Ethris
6.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business-Business Overview
6.10 GlaxoSmithKline Vaccines
6.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business-Business Overview
6.11 In-Cell-Art
6.12 Intellia Therapeutics
6.13 Janssen
6.14 Kernal Biologics
6.15 MaxCyte
6.16 Moderna Therapeutics
6.17 Novartis
6.18 PhaseRx
6.19 Precision NanoSystems
6.20 RaNa Therapeutics

7 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors-Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors-Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress-Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs-Customer Preference Change
10.3 Economic-Political Environmental Change

11 United States mRNA Vaccines & Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States mRNA Vaccines & Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States mRNA Vaccines & Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States mRNA Vaccines & Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology-Research Approach
13.1.1 Research Programs-Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of mRNA Vaccines & Therapeutics
Figure United States mRNA Vaccines & Therapeutics Market Size (K Units) by Type (2012-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Figure Infection Prevention MRNA Vaccine Product Picture
Figure United States mRNA Vaccines & Therapeutics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of mRNA Vaccines & Therapeutics by Application in 2016
Table Key Downstream Customer in Application 1
Table Key Downstream Customer in Application 2
Figure United States mRNA Vaccines & Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2022)
Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States mRNA Vaccines & Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) of Key Players-Suppliers (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Share by Players-Suppliers (2012-2017)
Figure 2016 United States mRNA Vaccines & Therapeutics Sales Share by Players-Suppliers
Figure 2017 United States mRNA Vaccines & Therapeutics Sales Share by Players-Suppliers
Figure United States mRNA Vaccines & Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Players-Suppliers (2012-2017)
Table United States mRNA Vaccines & Therapeutics Revenue Share by Players-Suppliers (2012-2017)
Figure 2016 United States mRNA Vaccines & Therapeutics Revenue Share by Players-Suppliers
Figure 2017 United States mRNA Vaccines & Therapeutics Revenue Share by Players-Suppliers
Table United States Market mRNA Vaccines & Therapeutics Average Price (USD-Unit) of Key Players-Suppliers (2012-2017)
Figure United States Market mRNA Vaccines & Therapeutics Average Price (USD-Unit) of Key Players-Suppliers in 2016
Figure United States mRNA Vaccines & Therapeutics Market Share of Top 3 Players-Suppliers
Figure United States mRNA Vaccines & Therapeutics Market Share of Top 5 Players-Suppliers
Table United States Players-Suppliers mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players-Suppliers mRNA Vaccines & Therapeutics Product Category
Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Region (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Share by Region (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Share by Region (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Region in 2016
Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States mRNA Vaccines & Therapeutics Revenue Share by Region (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2016
Table United States mRNA Vaccines & Therapeutics Price (USD-Unit) by Region (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Type (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Share by Type (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Share by Type (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Type in 2016
Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States mRNA Vaccines & Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type (2012-2017)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type in 2016
Table United States mRNA Vaccines & Therapeutics Price (USD-Unit) by Types (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Application (2012-2017)
Table United States mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Application in 2016
Table United States mRNA Vaccines & Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States mRNA Vaccines & Therapeutics Sales Growth Rate by Application (2012-2017)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table BioNTech Basic Information List
Table BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table CRISPR Therapeutics Basic Information List
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table CureVac Basic Information List
Table CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table eTheRNA immunotherapies Basic Information List
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table Ethris Basic Information List
Table Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Vaccines Basic Information List
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD-Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Revenue Market Share in United States (2012-2017)
Table In-Cell-Art Basic Information List
Table Intellia Therapeutics Basic Information List
Table Janssen Basic Information List
Table Kernal Biologics Basic Information List
Table MaxCyte Basic Information List
Table Moderna Therapeutics Basic Information List
Table Novartis Basic Information List
Table PhaseRx Basic Information List
Table Precision NanoSystems Basic Information List
Table RaNa Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players-Suppliers in 2016
Table Major Buyers of mRNA Vaccines & Therapeutics
Table Distributors-Traders List
Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Price (USD-Unit) Trend Forecast (2017-2022)
Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Type in 2022
Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Application in 2022
Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs-Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *